Pacylex submitted two abstracts for presentation at the 2019 American Association for Cancer Research (AACR) conference and both have been accepted. The AACR Annual Meeting program covers the latest discoveries across the spe

Pacylex presented its exciting anti-cancer story on January 7, 2019, at the 2019 Biotech Showcase™, an investor conference devoted to providing private and public biotechnology and life sciences companies with an opportunity

In partnership with the University of Alberta, Merck launched the Merck Invention Accelerator in a grand opening in Edmonton, Alberta, October 26, 2018. Pacylex was selected as one of the first 4 companies to participate in t